Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Novelion Therapeutics Inc (NVLNF)

Novelion Therapeutics Inc (NVLNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Novelion Therapeutics is a biopharmaceutical company. It engages in developing and marketing of ocular products for individuals living with rare diseases. The product portfolio includes MYALEPT(R) and JUXTAPID (R) and is also developing zuretinol and metrleptin. Novelion Therapeutics formerly known as QLT Inc. is headquatered in Vancouver, Canada.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2018 Dec, 2017 Dec, 2016 Dec, 2015 Dec, 2014
Sales 130,430 138,440 13,570 0 0
Sales Growth -5.79% +920.19% unch unch unch
Net Income -108,330 -126,710 -52,870 -23,010 -4,070
Net Income Growth +14.51% -139.66% -129.77% -465.36% +83.63%

Balance Sheet

(Values in U.S. Thousands) Dec, 2018 Dec, 2017 Dec, 2016 Dec, 2015 Dec, 2014
Total Assets 341,720 369,320 480,780 145,170 160,370
Total Assets Growth -7.47% -23.18% +231.18% -9.48% -2.14%
Total Liabilities 430,580 354,380 345,000 3,830 3,860
Total Liabilities Growth +21.50% +2.72% +8,907.83% -0.78% -36.51%

Cash Flow

(Values in U.S. Thousands) Dec, 2018 Dec, 2017 Dec, 2016 Dec, 2015 Dec, 2014
Operating Cash Flow -55,470 -54,900 -34,360 -19,360 460
Operating Cash Flow Growth -1.04% -59.78% -77.48% -4,308.69% +101.78%
Net Cash Flow -10,280 -53,500 -32,900 -14,080 37,390
Change in Net Cash Flow +80.79% -62.61% -133.66% -137.66% +119.80%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot